Pharma Marketing Academy
Pharma Marketing Academy consults and partners with clients worldwide to achieve meaningful and lasting improvements in the marketing knowledge, skills and performance of their people. We leverage our practical pharma marketing and training expertise to build and deliver world-class learning solutions that make a tangible difference to the business.
This is a FREE LISTING on PMHUB
Below are full profiles from other companies in related areas
Amiculum
AMICULUM works with the global healthcare industry to bring science to life across the product lifecycle from early opportunity assessment through to launch and beyond. By listening to the changing…
Dice Medical Communications
Dice Medical Communications is an independent communications agency that works with our clients to help launch, build, and continually develop great pharmaceutical brands. We do this by creating Pharmacohesion™.
Impetus Digital
Impetus Digital has offered virtual advisory boards, clinical trial investigator consortiums, co-author publication working groups, steering committees, and medical education to life science companies from around the globe since 2008.
M3 (EU)
M3 has over 20 years’ experience in building online doctor communities. M3 is the world’s largest network of verified doctors with over 6 million members across M3-owned networks and an…
OPEN Health
OPEN Health brings together deep scientific knowledge, global understanding, and broad specialist expertise to support our clients in improving health outcomes and patient wellbeing.
Company Details
Latest Content from PMHub
Why stigma is a launch risk in rare disease – and what commercial leaders can do about it
White Papers and Resources | March 2, 2026 | Havas Life London
Rare disease launches are complex by nature. Yet one of the most consistent risks we see is rarely treated as a launch issue at all: stigma.
From ‘why’ to ‘how’: patient partnership across age groups in research and publications
White Papers and Resources | February 27, 2026 | Amiculum
By Sarah Mohamad
From Static to Strategic: The 2026 Playbook for Longitudinal Pharma Interaction
Press Releases | February 26, 2026 | Impetus Digital
Stop pushing content at a burnt-out audience and start creating "Digital Magnetism." Join Impetus Digital to unlock the 2026 Engagement Toolkit—a deep dive into the immersive, longitudinal strategies and newly...
Data, Evidence, Education: Tackling the Global Multi‑Trillion‑Dollar Rare Disease Burden
Press Releases | February 25, 2026 | Medscape Education
Rare diseases are individually uncommon, yet together they affect an estimated 300 million+ people worldwide and touch the lives of over one billion when families and caregivers are included. For...
T40: when a number is not just a number
Press Releases | February 23, 2026 | Grace Communications
Proud to be ranked 3rd among the Top 10 UK-focused agencies, along with other categories, Grace Communications finds inspiration in being included in PMLive’s Top 40 Creative Healthcare Agencies 2025.
Why patient engagement must come first in rare disease trials
White Papers and Resources | February 23, 2026 | Cuttsy + Cuttsy
Explore why patient engagement is the cornerstone of successful rare disease trials, emphasising the importance of designing studies around the realities of patients' lives to build trust and improve outcomes.
New Cuttsy+Cuttsy research shows why site support matters more than ever
Press Releases | February 23, 2026 | Cuttsy + Cuttsy
Cuttsy+Cuttsy's upcoming report, 'The site factor: Where protocol meets practice in clinical trials', delves into the critical role of site staff in clinical research, offering insights into their daily challenges,...
#ShortenTheJourney
Press Releases | February 18, 2026 | Medscape Education
For the millions of people living with a rare disease, the path to a diagnosis (if ever received) is often a long and frustrating odyssey. This delay is frequently driven...
Why We Must Stop Normalizing the “Pregnancy Itch”
Press Releases | February 18, 2026 | Medscape Education
In the world of rare diseases, success is often measured by the speed of diagnosis. However, for women facing rare liver conditions like Intrahepatic Cholestasis of Pregnancy (ICP), the medical...
Winning in Pharma: the power of early strategic planning with patients
White Papers and Resources | February 17, 2026 | Amiculum
By Zoë van Helmond